• Sneh Priya Nitte University
  • Marina Koland
  • Suchetha Kumari N


Objective: Correct selection of oils, surfactants, and co surfactants along with their optimum concentration is essential to get stable and clinically
acceptable nanoemulsions. The aim of the present study was, to provide an efficient screening approach for the excipients selection for the optimum
nanoemulsion formulation development.
Methods and Results: The solubility of quetiapine (QTP) fumarate in the oils (Capryol 90, isopropyl myristate, castor oil, and olive oil), surfactants
(labrasol, cremophor EL, Brij L23, Tween 20, and Tween 80), and co surfactants (ethanol, isopropyl alcohol, and propylene glycol) was taken as the
criterion for selection. The maximum solubility of QTP was found to 35.54±0.91, 40.4±0.83, and 32.07±0.92 in Isopropyl myristate, Tween 20, and
propylene glycol, respectively. The effect of Tween 20/propylene glycol mass ratio on the nanoemulsion formation was also studied by varying the
ratio from 3:1 to 1:0 for the further optimization of the system. The highest nanoemulsion region was obtained at Tween 20/propylene glycol in
the mass ratio of 3:1. Formulations were selected from the phase diagram at which concentration of oil was constant with increasing (30, 35, 40,
45% wt/wt) concentration of surfactant/co surfactant mass ratio (Smix) and subjected to thermodynamic stability tests. The optimized formulations
were characterized for particle size, viscosity, pH and refractive index measurements. All the selected formulations were found to be stable, and the
droplet size was found to be <100 nm.
Conclusion: The formulations were thermodynamically stable and can be effectively used for the drug delivery applications.


1. Bhosale RR, Osmani RA, Ghodake PP, Shaikh SM, Chavan SR.
Nanoemulsion: A review on novel profusion in advanced drug delivery.
Indian J Pharm Biol Res 2014;2(1):122-7.
2. Maali A, Mosavian MT. Preparation and application of nanoemulsions
in the last decade (2000-2010). J Disper Sci Tech 2013;34(1):92-105.
3. Ghosh PK, Majithiya RJ, Umrethia ML, Murthy RS. Design and
development of microemulsion drug delivery system of acyclovir
for improvement of oral bioavailability. AAPS PharmSciTech
4. Azeem A, Rizwan M, Ahmad FJ, Iqbal Z, Khar RK, Aqil M, et al.
Nanoemulsion components screening and selection: A technical note.
AAPS PharmSciTech 2009;10(1):69-76.
5. Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K.
Intranasal nanoemulsion based brain targeting drug delivery system of
risperidone. Int J Pharm 2008;358(1-2):285-91.
6. Kumar M, Misra A, Mishra AK, Mishra P, Pathak K. Mucoadhesive
nanoemulsion-based intranasal drug delivery system of olanzapine for
brain targeting. J Drug Target 2008;16(10):806-14.
7. Morsi NM, Mohamed MI, Refai H, Sorogy HM. Nanoemulsion as
a novel ophthalmic delivery system for acetazolamide. Int J Pharm
Pharm Sci 2014;6(11):227-36.
8. Lv FF, Li N, Zheng LQ, Tung CH. Studies on the stability of the
chloramphenicol in the microemulsion free of alcohols. Eur J Pharm
Biopharm 2006;62(3):288-94.
9. Nasr M, Nawaz S, Elhissi A. Amphotericin B lipid nanoemulsion
aerosols for targeting peripheral respiratory airways via nebulization.
Int J Pharm 2012;436(1-2):611-6.
10. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S. Nanoemulsions
as vehicles for transdermal delivery of aceclofenac. AAPS
PharmSciTech 2007;8(4):E104.
11. Shinde PB. Component screening of miconazole nitrate nanoemulsion.
Asian J Biomed Pharm Sci 2013;3(19):33-40.
12. Ahmed M, Ramadan W, Rambhu D, Shakeel F. Potential of
nanoemulsions for intravenous delivery of rifampicin. Pharmazie
13. Mundo E, Cattaneo E, Zanoni S, Altamura AC. The use of atypical
antipsychotics beyond psychoses: Efficacy of quetiapine in bipolar
disorder. Neuropsychiatr Dis Treat 2006;2(2):139-48.
14. Sudarshan RP, Panjagala S, Karthik VK, Raju N, Siva KG,
Shanmugasundaram P. Novel reverse phase HPLC method development
and validation of quetiapine fumarate in bulk and tablet dosage form.
Int J Pharm Ind Res 2011;1(2):95-9.
15. Delmas T, Piraux H, Couffin AC, Texier I, Vinet F, Poulin P, et al.
How to prepare and stabilize very small nanoemulsions. Langmuir
16. Borhade V, Pathak S, Sharma S, Patravale V. Clotrimazole
nanoemulsion for malaria chemotherapy. Part I: Preformulation studies,
formulation design and physicochemical evaluation. Int J Pharm
17. Narang AS, Delmarre D, Gao D. Stable drug encapsulation in micelles
and microemulsions. Int J Pharm 2007;345(1-2):9-25.
18. Bouchemal K, Briançon S, Perrier E, Fessi H. Nano-emulsion
formulation using spontaneous emulsification: Solvent, oil and
surfactant optimisation. Int J Pharm 2004;280(1-2):241-51.
19. Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K,
Nishihara Y, et al. Microemulsion formulation for enhanced absorption
of poorly soluble drugs. I. Prescription design. J Control Release
20. Lin TJ. Effect of initial surfactant locations on the viscosity of
emulsions. J Soc Cosmet Chem 1968;19(10):683-97.
255 Views | 1032 Downloads
How to Cite
Priya, S., M. Koland, and S. K. N. “NANOEMULSION COMPONENTS SCREENING OF QUETIAPINE FUMARATE: EFFECT OF SURFACTANT AND CO SURFACTANT”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 8, no. 6, Nov. 2015, pp. 136-40,
Original Article(s)